Adrian Haigh - 15 Apr 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Signature
/s/ Adrian Haigh
Issuer symbol
FENC
Transactions as of
15 Apr 2024
Net transactions value
-$457,182
Form type
4
Filing time
16 Apr 2024, 18:00:52 UTC
Previous filing
07 Aug 2023
Next filing
26 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Sale $51,333 +22,222 $2.31 22,222 15 Apr 2024 Direct F1
transaction FENC Common Shares Sale $51,333 +22,222 +100% $2.31 44,444 16 Apr 2024 Direct F2
transaction FENC Common Shares Sale $228,793 -22,222 -50% $10.30 22,222 15 Apr 2024 Direct F3
transaction FENC Common Shares Sale $228,389 -22,222 -100% $10.28 0 16 Apr 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Common Shares Options Exercise $51,333 -22,222 -4.5% $2.31 471,357 15 Apr 2024 Options 22,222 $2.31 Direct F5
transaction FENC Common Shares Options Exercise $51,333 -22,222 -4.7% $2.31 449,135 16 Apr 2024 Options 22,222 $2.31 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
F2 Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
F3 Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
F4 Shares acquired pursuant to a 10b5-1 plan dated August 17, 2023.
F5 Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
F6 Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.